ProfileGDS4718 / 201027_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 86% 79% 85% 80% 81% 93% 89% 84% 81% 85% 87% 79% 91% 92% 89% 88% 84% 90% 89% 86% 84% 83% 84% 85% 87% 87% 82% 88% 84% 91% 88% 92% 77% 86% 87% 91% 88% 83% 80% 88% 85% 89% 85% 94% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]8.6651486
GSM549102patient 115, normal, homogenized [OPG study]7.645779
GSM549104patient 119, normal, homogenized [OPG study]8.5910485
GSM549108patient 138, normal, homogenized [OPG study]7.7944480
GSM549119patient 077, normal, homogenized [OPG study]7.9202781
GSM549133patient 032, cancer, homogenized [OPG study]9.7964193
GSM549139patient 042, cancer, homogenized [OPG study]9.0051589
GSM549099patient 107, normal, homogenized [OPG study]8.2748384
GSM549109patient 139, normal, homogenized [OPG study]7.9277881
GSM549110patient 046, normal, homogenized [OPG study]8.4852185
GSM549114patient 063, normal, homogenized [OPG study]8.847287
GSM549122patient 082, normal, homogenized [OPG study]7.7044879
GSM549134patient 033, cancer, homogenized [OPG study]9.4368691
GSM549136patient 036, cancer, homogenized [OPG study]9.5174492
GSM549140patient 044, cancer, homogenized [OPG study]9.0871489
GSM549111patient 047, normal, homogenized [OPG study]9.0139288
GSM549113patient 057, normal, homogenized [OPG study]8.5188184
GSM549132patient 031, cancer, homogenized [OPG study]9.2269190
GSM549137patient 038, cancer, homogenized [OPG study]8.9888489
GSM549142patient 047, cancer, homogenized [OPG study]8.2677386
GSM549100patient 110, normal, homogenized [OPG study]8.282284
GSM549107patient 135, normal, homogenized [OPG study]8.1900383
GSM549115patient 068, normal, homogenized [OPG study]8.4984884
GSM549116patient 072, normal, homogenized [OPG study]8.598485
GSM549120patient 078, normal, homogenized [OPG study]8.7894987
GSM549131patient 030, cancer, homogenized [OPG study]8.8442687
GSM549118patient 074, normal, homogenized [OPG study]8.171582
GSM549129patient 027, cancer, homogenized [OPG study]8.786388
GSM549123patient 088, normal, homogenized [OPG study]8.3369584
GSM549124patient 006, cancer, homogenized [OPG study]9.1355191
GSM549126patient 015, cancer, homogenized [OPG study]8.8868588
GSM549128patient 025, cancer, homogenized [OPG study]9.6115992
GSM549103patient 117, normal, homogenized [OPG study]7.3742677
GSM549117patient 073, normal, homogenized [OPG study]8.6816186
GSM549138patient 041, cancer, homogenized [OPG study]8.7044987
GSM549141patient 045, cancer, homogenized [OPG study]9.3978391
GSM549130patient 028, cancer, homogenized [OPG study]8.7319688
GSM549101patient 111, normal, homogenized [OPG study]8.1416783
GSM549105patient 128, normal, homogenized [OPG study]7.806580
GSM549106patient 134, normal, homogenized [OPG study]9.0129588
GSM549112patient 048, normal, homogenized [OPG study]8.4647885
GSM549125patient 011, cancer, homogenized [OPG study]8.8942289
GSM549127patient 024, cancer, homogenized [OPG study]8.3866885
GSM549135patient 035, cancer, homogenized [OPG study]9.9747694